MétaCan
Menu
Retour à la cohorte
Enregistrement W2095451629 · doi:10.1097/01.inf.0000196485.86376.46

Advances in Prevention of Cervical Cancer and Other Human Papillomavirus-Related Diseases

2006· review· en· W2095451629 sur OpenAlex
Ian H. Frazer, J. Thomas Cox, Edward J. Mayeaux, Eduardo L. Franco, Anna-Barbara Moscicki, Joel M. Palefsky, Daron G. Ferris, Alex Ferenczy, Luisa L. Villa

Pourquoi ce travail est dans la base

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

affAu moins un auteur déclare une institution canadienne dans l'instantané OpenAlex épinglé.
aboutLe titre ou le résumé porte un signal canadien du lexique géographique.

Notice bibliographique

RevueThe Pediatric Infectious Disease Journal · 2006
Typereview
Langueen
DomaineMedicine
ThématiqueCervical Cancer and HPV Research
Établissements canadiensJewish General HospitalMcGill University
Organismes subventionnairesNational Cancer InstituteWorld Health Organization
Mots-clésMedicineHuman papillomavirusCervical cancerPapillomaviridaeCancerVirologyOncologyInternal medicine

Résumé

récupéré en direct d'OpenAlex

In theory, recognition that a pandemic infection is responsible for more than half a million cancer cases each year would attract huge media attention, and infection control would become the subject of preventative efforts from all global health agencies. Media attention would likely be particularly acute if the majority of deaths was among women rearing families in the developing world and if the disease were sexually transmitted. A vaccine capable of preventing the disease would be diligently pursued and, once available, promptly distributed for the health and welfare of humankind. Human papillomavirus (HPV) infection fits this scenario; however, HPV has yet to make an impact on either the media or public thinking as outlined in the previous paragraph, even though the link between HPV infection and cervical cancer has been recognized for more than 20 years. It is possible that the delay between acquisition of HPV infection and death, on average 20 years, or the asymptomatic nature of acute infection, greatly diminishes the immediacy of the public impact of this epidemic. Although apparently safe vaccines capable of preventing >90% of HPV infections are in the offing, focus on prevention of HPV associated deaths is being diverted by debates about the morality of vaccination against a sexually transmitted infection and its hypothesized impact on human sexual behavior. A roundtable discussion was held in Vancouver, British Columbia to consider and develop a consensus statement among informed clinicians about HPV infection, the role of HPV in cervical cancer, the role of HPV in other anogenital malignancies, the role of HPV in genital warts and the prospects for control of the global HPV pandemic through vaccination. The consensus statements outlined within have been agreed upon and represent the informed opinions of this expert working group. CONSENSUS 1: GENITAL HPV-ASSOCIATED DISEASE IS A MAJOR HEALTH CARE BURDEN HPV infection is the cause of genital warts and most preinvasive and invasive cancers of the lower anogenital tract. Clinically or histologically recognized genital warts, abnormal cervical cytology and preinvasive or invasive cancer are major causes of physical and psychologic morbidity and of treatment-related cost. The Causal Relationship Between HPV and HPV-Associated Diseases Papillomaviruses are small, nonenveloped viruses that infect cutaneous and mucosal epithelial tissues. More than 100 types of HPV have been identified, of which more than 40 infect the genital mucosa (Fig. 1). 1 The life cycle of HPV is dependent on active cellular replication and subsequent cellular division. Because the uppermost layers of the squamous epithelium have undergone terminal differentiation and are no longer dividing, HPV requires access to the undifferentiated basal layer of the epithelium to initiate a productive infection cycle. Current hypotheses suggest that HPV accesses the underlying basal layer through naturally thin epithelial layers, such as those found in the transformation zones of the cervix or anus, or through microabrasions in the epithelium produced during sexual activity.2 Once infection has been established, the virus uses host cell machinery to replicate viral genetic material and express viral proteins. Because viral replication is dependent on continued cellular division, the virus has evolved to express proteins that inhibit cellular differentiation and stimulate continued cellular proliferation (Fig. 2) (for an in-depth review of HPV pathology, see Reference 3). Therefore, unrestricted cell growth is the hallmark of HPV infection, and many HPV-associated clinical manifestations can be explained by these molecular mechanisms.FIGURE 1.: Phylogenetic tree containing the sequences of 118 papillomavirus types.1FIGURE 2.: Natural history of HPV infection of mucosal epithelial layers. A, HPV infects the basal layer of the epithelium. B, The virus uses host cell machinery to replicate viral DNA and express virally encoded proteins. C, Viral particles are formed and released.3High Risk HPV Infections Genital HPV types have been separated into high and low risk groups depending on the observed risk of malignant progression (Table 1). The distinction between high and low risk HPV types has been made primarily because clinical diseases caused by infection with low risk HPV types are usually clinically benign and rarely progress to neoplasia. High risk HPV types are responsible for most high grade, precancerous lesions and >99.7% of cervical cancers.4 HPV is the cause of more than half of all invasive the of HPV HPV and HPV have that HPV and are responsible for of all cervical cancers and the majority of precancerous during cervical cancer cytology The for of HPV in cervical cancer is that the for on of the and the have high risk HPV as a human The has recognized HPV as a human and and the in 1: of Genital HPV the of cervical cancer was about the of cervical cancer disease however, the history of cervical cancer is in because of cervical cancer and Although cervical is HPV infections are to cause low which progress to high lesions and to in and cervical cancer (for an in-depth review of the history of cervical cancer, see Reference associated with cervical cancer has the of the and of cervical cancer in most an million are in the a each year million women are with squamous million with low squamous lesions with high squamous lesions and with cervical an women in the of cervical cancer The associated with HPV infection is the of cervical cancer and of preinvasive and invasive for the from 1 to HPV the most sexually transmitted infection to human virus associated with HPV infection cervical of low and high of cervical cancer and to of (Fig. 3). Although the and health associated with can has that and of low and high lesions and the and associated with cervical cancer and of abnormal were these would HPV-associated in the is that HPV is a cause of cervical and a role for high risk HPV types in the of other malignant genital and mucosal lesions is HPV has been to the of a of and and cancers The and associated with these cancers are however, the role that HPV in the of each of these cancers is an of have a between HPV infection and The of cancer is in the and are particularly high in have with and are such as The role of HPV in the of and cancer is by health and is to of HPV and HPV-associated disease be in in this Risk HPV Infections with low risk HPV types is associated with clinical diseases that epithelial In to of infection with low risk HPV is responsible for all cases of and all anogenital Although or genital warts, are clinically are a cause of morbidity in and HPV types and the most low risk HPV are responsible for of genital Current suggest that of the sexually active has genital and the for and that genital warts to in to of all to sexually transmitted disease are or of the and usually to be to of genital warts within of associated with are has that the average for of the are as is and is most (Fig. associated with of genital warts in the of and subsequent and of is a of HPV infection in is caused by benign by HPV or infection of the with are during the infection to to cases of are and and to year to to of with of the of HPV associated with HPV infection are to It is that HPV is a of psychologic among develop or are with genital warts, have an abnormal or are for precancerous lesions or invasive It has been that many of these and are on by of associated with acquisition of an that have develop that with and with genital warts or and with precancerous women have with and for all of which of of cervical and develop that to sexual or with and in the of HPV-associated disease would be to of psychologic and health CONSENSUS GENITAL HPV HPV-ASSOCIATED DISEASE IS sexually active and women genital HPV infection The risk of infection with each be of and of HPV and HPV is the most in the In the an 20 million are with this with million infections each of the has been or become (Fig. the majority of sexually active from to are risk for Although and women of represent of the sexually active of half of all are in this (Fig. The of active HPV infections in and in the is however, a more is the of infections that are by this group. suggest that of all or million cases among and women of (Fig. of the to of sexually transmitted infections among HPV causes an million infections among and have on the of HPV infection among and the of HPV infection has been in sexually active women of and (Fig. In an of of for cervical or HPV More have of cervical HPV infection to be between and In that of or of of for HPV during a these the of HPV infection among and of high risk HPV infections among women in history of HPV infection in high risk have on associated and risk A of women in the of the of infection among sexually active women were with that of to initiate sexual The were and for and of women HPV infection within of in the (Fig. of women a in that of women HPV infections within of in the In a of sexually active the of HPV infections among women of was during a in a women in the of women of HPV within of The risk for HPV was a sexual each sexual in the the risk for HPV was In a an of sexual was with of HPV of women were with of women were In can that half of all sexually active and and women HPV infection within of the of sexual and suggest that sexual is the most risk for HPV of HPV infections among women HPV and among sexually active risk of sexual and a history of virus a history of genital warts is associated with an risk of cervical HPV with are because can cause and in the HPV access to the basal epithelium. Although the by which these risk acquisition of HPV infection are most can be associated with sexual and are to an risk of of HPV-Associated in and the that and are most risk for developing low HPV and of are among women than of (Fig. Between 20 and of women with HPV develop within of HPV infection (Fig. Although high of are to be a of high of HPV in this has been hypothesized that women be an risk because of cervical cervical the squamous of the cervix naturally squamous a of cell differentiation and of epithelium is a host to HPV because requires cell differentiation and replication to and viral the developing squamous epithelium can be more to infection with HPV in of and women develop low cervical however, the majority of low lesions in women within of The of and the for cervical cancer of be in a to the high of is among are and and because of HPV these are a risk of developing HPV-associated be for the of high lesions and for of and cervical women with HPV of are among for genital warts among and women are with for women between 20 and of and for between and of among between the groups of and years. as with HPV infections and the of cervical genital warts are most among and The of in the of HPV and the of HPV-Associated Diseases It has been hypothesized that HPV rarely infects the cervix in the of sexual that HPV can be transmitted to the or in the of sexual women in sexual most likely for cervical and women most likely for anogenital In of this HPV DNA was the in of no HPV DNA was observed in these women on the cervical infection, infection, most likely requires from the the cervix and many to and during A of 20 was to is against HPV infection or of HPV-associated The from the were that against HPV infection that of against the of HPV-associated In a that HPV infection among women were likely to have of cervical HPV infection than those HPV infects that are of those by a be informed that of against infection of the however, against infection of other anogenital is of many and most be to and during all of sexual have that the of HPV-associated diseases and in were likely to develop genital warts than those In a and women were likely to be with genital have been for cervical In a by and women were likely to have high lesions than those women were to have a risk of developing has that of HPV infection and in In this women with cervical were to a of for women The by which are however, the of virus viral the of other that be in the of in and the of HPV-associated CONSENSUS IS A HPV HPV-ASSOCIATED DISEASE women become with high risk HPV in the of develop precancerous lesions that progress to infection with high risk HPV types is a major for developing high preinvasive cervical High Risk HPV are the Infections It is that HPV is and that most sexually active become to HPV in many have that high risk HPV types are the most HPV infections develop or malignant anogenital the of of HPV is of for clinicians and health for women of all In a of high risk HPV infections were observed more than low risk among women of the of low risk types was lower than that observed for high risk types in each (Fig. In a of women for high risk HPV types was for low risk the of high risk infections was with for low risk in a of women in of all infections were as high were low risk were with high and low risk and were HPV high risk HPV HPV is responsible for of all cervical cancers and is by the most HPV In asymptomatic the of HPV has been to from to of all of high and low risk HPV HPV and High Risk the many history each has that of HPV infection, as of HPV DNA of the HPV among or more is the risk for developing cervical HPV infections rarely cause disease because most infections are The nature of infection is for low and high risk HPV that of infections within In the average to of high and low risk HPV infections was and (Fig. have longer of and however, in most all HPV infections become by molecular within to of and HPV The average to was and for low and high risk HPV for of active infection are the cellular is in HPV however, is possible that the life cycle of by is have that the the virus into a of of viral is more because the virus would be to and cause infection as and naturally the to HPV infection is an of and into the the of HPV in because most infections are or clinicians the of HPV DNA to and that infection, or of is associated with developing high infections that are by the are associated with HPV-Associated to The of cervical cancer is to many of which infection with high risk HPV is to (Fig. to of most HPV-associated lesions of is to the A of history that women were with or was to of all of as squamous of of and of to of of and of to more lesions during a for progression to invasive cancer were even and for and during a have lesions that high risk HPV HPV or lesions with HPV types longer to than those with low risk for from to from to or and from to or were from to to and to with low and high risk HPV The of the however, that as the of progression the for progression of with high risk HPV are and from for to or to for progression from to or of progression cervical cancer has been the of cervical progression to cervical cancer is a that to because of women with be to The of and and for and have all for the of abnormal cytology and for women with A of cervical groups of women are or risk of are an risk for developing HPV-associated and are most among women than of (Fig. in and >90% of within (Fig. than of low lesions progress to more lesions in and no cases of cervical cancer were in women than 20 of from to these and have been for as and in women can be of are are an risk of developing have that HPV infections and HPV-associated lesions longer in with cellular these be with low and high of low squamous in low lesions within of HPV IS A have with and have with women are risk for developing anogenital cancers can be the and of HPV most likely be among and women The and of HPV infection and among and are high The of cancer is in the and is particularly high in have with HPV and HPV-Associated in high risk HPV infections in are and in HPV-associated however, HPV has been to and cancer in Although the history of HPV infection in is is that are with HPV and subject to developing HPV-associated of HPV infection in are to those in from to however, are by the that the majority of HPV infections are in and that the on the to for HPV DNA in is The of HPV infection for are to those for women and are to sexual behavior. The risk for genital HPV infection in was of by and a history of genital warts, or an of with and to were all associated with an risk of HPV were more likely to than with of of for HPV The role of as of HPV as as for is have that of cancer are an risk of developing cervical cancer in and HPV DNA is found more in of women have cervical than of of women with of HPV In a the of HPV DNA in a was associated with a risk of developing cervical preventing infection in and women would be to HPV-associated morbidity and in clinical are to the of with HPV vaccines are to be in be an in HPV-associated disease in and an Risk for HPV and Although the history of cancer is the progression of high lesions to cancer is hypothesized to be to the progression of high cervical lesions to cervical to the genital the has a transformation the squamous epithelium the epithelium from the HPV access to the basal cell layer through this naturally thin epithelial layer or through microabrasions during all and in are risk for HPV infection and developing HPV-associated be in are risk for HPV infection and developing and have of with have of all in were with Therefore, the risk of HPV infection and developing is for the Because is associated with an risk of HPV infection, have with are an risk for HPV In of for HPV cervical HPV infection, for HPV infection with In a of sexually active of HPV infection between and for all groups (Fig. in are with to of for HPV to cervical HPV high risk HPV infections are the most infections in of HPV infection and squamous in have with squamous are a risk of developing precancerous and lesions than are have with women or those in The of low and high is high in as with HPV infection, of and high in all groups of (Fig. those with are an even risk of developing HPV-associated than a of were with high with of are to those observed for the of of were with high with of risk associated with the of high disease lower cell and infection with with a risk of developing high disease between and than those were The of high disease among with HPV infection was with of no HPV (Fig. to cervical infection, these the of HPV infection in the progression of for the of in with and HPV the in the was observed that of cancer than women for cervical cancer in the suggest that women develop cervical cancer and that as many as develop is to be in of develop cancer found that a risk of developing cancer with the It be that all are risk for developing all with the risk of developing squamous cell cancer among of is than for for cancer in has been and has that in life would be with other clinical preventative CONSENSUS HPV A GENITAL HPV vaccines for HPV are to anogenital HPV infection in women and are likely to greatly the HPV-associated health HPV vaccines be particularly to women have sexual however, sexually active are to vaccine HPV types from vaccination HPV vaccines to be and in preventing infection in be for vaccination and are likely to the public health and be as vaccines become HPV vaccination has to be an to morbidity and vaccination has the of infection by for B, for and and has and (Fig. that against HPV infection are in the of clinical and have the to greatly the HPV-associated disease have the of HPV vaccines are of the major of the HPV is in a such as or into or that the of HPV in and have that of are and no genetic Because are have no or and are for as of in and that to HPV preventing into The vaccines were to in to the and of in the HPV and HPV a of women of with no history of abnormal cervical cytology and no history of genital warts were to between and 100 of or and and were for vaccines among women with high of by (Fig. in and of women with HPV and HPV were with the as the most HPV in women with HPV of the HPV as vaccines were in women of were to a of HPV vaccine or and were for a of the vaccination genital were to for HPV DNA and to the of HPV infection, as of HPV DNA or more the women the vaccine infection during the of the with cases of infection in the women the vaccine was in preventing of all women the vaccine and produced that were than those produced as a to HPV The vaccine was with no and in the vaccine of the with in the caused by a The from this the and of as vaccines and that vaccines can infection, the most risk for developing HPV-associated cervical Natural HPV infection to HPV are with HPV and of against infection with that HPV to other HPV to the public health HPV be to against the most HPV vaccines are in of clinical on a vaccine that is to against the most HPV HPV and would of all low cervical lesions and of high precancerous lesions and invasive HPV types would be to even more HPV-associated disease (Fig. A vaccine that against HPV types and as as low risk HPV types and would be to an of low cervical lesions and all cases of genital of these vaccines have and and have the to disease in cervical cancer with of HPV vaccine women of vaccine of 20 each of HPV and with or 1 and and women for to the vaccine was to be in the against cervical infection, and against HPV or cervical infection (Fig. vaccine was to be against infection and against HPV or in women the the with of the vaccine was with no of a HPV vaccine that against HPV and were observed with the was and and women of The vaccine 40 and 20 of HPV and and was and were observed during a with of infection or the of in the was for infection and for prevention of clinical disease associated with HPV or (Fig. observed for the were The vaccine was in preventing infection and against HPV or clinical were no the of vaccines in of a HPV vaccine that against HPV and from the to disease clinical were The HPV vaccine was preventing and cervical cancer associated with HPV or infection during of The vaccine was and were no of HPV It is that HPV vaccines are and however, many the of HPV is the of of vaccine HPV vaccines that are to than those by infection, the that this has on the of is in the public suggest that can be for is about longer the that against infection is of become an in be and of the be have been that have the and public health impact of with each focus on and because vaccination be most to the virus and sexual Although the average of sexual is in the many in of sexual many the become sexually active be into by and health for to In was to life by or life a of to a vaccination years. life have been for vaccination against and with each and The found that the of would HPV abnormal and cases of cervical A found that and cervical cancer of would in of in cervical cancer cases and in vaccination cervical cancer an in and an in this was more of the found that were into the cervical cancer of cervical cancer and of with of the most of and women was to be more in HPV infection and HPV-associated disease than that and women would in a in the of the women would by of and to be cervical cancer cases caused by HPV by a of and HPV-associated cancers by with a of and vaccine be by public health HPV vaccination to the of as as are HPV vaccines are to be in and vaccination vaccination of these groups to HPV in the vaccination of other such as women are with low or high cervical be is most and women be with each of the vaccine HPV vaccination would be to be vaccines are in is the consensus of this working that sexually active can from vaccination and be the to become CONSENSUS HEALTH CARE HPV and to be if are to be in cervical cancer and from health and be to vaccine an and Although vaccines debates among and other of vaccination against an infection transmitted through sexual and that are with other or because HPV vaccines are of vaccination be of sexual which the of disease prevention the of the vaccine with of risk of and health and to the disease and of the disease about vaccines and vaccine and such as vaccine are that were to be an would be In the of for vaccination because be as an of risk for an that be observed by health is that vaccination likely if the is a sexually active sexual or with that is risk for infection or be that of vaccination against HPV be as an of and an to be to vaccines for of the of and are and be It has been that vaccines against to a in and in sexual that are for or for sexual and these and to the most vaccination HPV and and It is that and women have a of the of the diseases HPV or the between genital HPV infection and genital warts, abnormal and cervical In 1 of women that of even women been with an abnormal or undergone the link between cervical and HPV have with of of HPV and of genital about HPV in was to be even of high that of the In than half of HPV as a of sexually active risk for an is that and be about the of HPV and the associated with have that many women are in about HPV and that efforts be on have sexual Although media of HPV has the of HPV DNA for cervical cancer of the is and HPV and to infection and Because and from health have been to be the most in to HPV and for and in and about to vaccination is of if the public health of HPV vaccines are to be health develop with and to the associated with acquisition of HPV and the associated with have the of health about HPV vaccines to from the of the of and the on be for to from health and from be for the and of HPV through can the of HPV have the role that HPV vaccines in the of cervical cancer Although cervical cancer most likely to initiate or if between can be be by women to be to and

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesCharge utile insuffisante (le modèle a refusé de juger)
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Autre devis · Signal consensuel: aucune
GenreSignal candidat: Synthèse · Signal consensuel: Synthèse
Score de désaccord entre enseignants0,789
Score d'incertitude au seuil0,999

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0010,001
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,001
Charge utile insuffisante (le modèle a refusé de juger)0,0020,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,030
Tête enseignante GPT0,398
Écart entre enseignants0,368 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle